Our approach
Preeclampsia is not one uniform disease. Different biological processes can lead to the same diagnosis, and those differences matter when we try to prevent it.
Prevention first
Once preeclampsia appears, medicine manages it well: blood pressure is controlled, the pregnancy is watched closely, and delivery is timed to keep mother and baby safe. Most of the resources are directed there.
The focus of Inheren is prevention. That means the earlier window: finding the women at risk early, and lowering that risk while there is still time.
Once a woman understands her risk, the questions are practical. What can she do to lower it? When does she start?
Why one plan does not fit
Clinical trials generally report average treatment effects. But women do not all develop preeclampsia through the same biological mechanisms, and they do not necessarily respond to the same interventions.
A treatment may be effective in a biologically appropriate group while appearing ineffective when studied across a population that includes many women who would not be expected to respond. We need to understand those differences rather than dismiss useful interventions because the average result was disappointing.
How Inheren works with it
The approach begins with the woman's history, her underlying biology, and the evidence supporting prevention. A previous pregnancy can tell us a great deal. So can nutritional status, metabolic health, vascular function, and other measurable factors.
The goal is to identify what can be changed before another pregnancy becomes complicated. That may involve several prevention strategies working together rather than relying on one intervention. The Companion is built to help women understand that evidence, recognize what applies to them, and participate meaningfully in decisions with their clinical teams.
See Preventing PreeclampsiaThe longer view
It is part of a bigger picture. In 2020 the American Heart Association formally listed adverse pregnancy outcomes — including preeclampsia — as risk-enhancing factors for cardiovascular disease. The biology was understood long before the guideline caught up to it.
Preventing preeclampsia is the near-term goal. Understanding what it says about a woman's long-term heart and metabolic health is the longer one. Both belong to the same work.
About Dr. JenkinsTo be clear
Inheren builds education and tools that help a woman understand and lower her risk of preeclampsia. It is not a clinic, and the Companion is not a doctor. It does not diagnose or treat, and it does not replace her obstetrician or primary care doctor.